Sana Biotechnology (NASDAQ:SANA) reported quarterly losses of $(0.39) per share. This is a 21.88 percent decrease over losses of $(0.32) per share from the same period last year.
Estee Lauder May Lose Share In North America, But Not This Region: Analyst
RBC Capital Markets analyst Nik Modi reiterated Outperform rating on Estee Lauder Companies, Inc. (NYSE: EL),
